[{"address1": "One Kendall Square", "address2": "4th Floor Suite B14402 Building 1400 West", "city": "Cambridge", "state": "MA", "zip": "02139", "country": "United States", "phone": "617 863 5500", "website": "https://www.invivotherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "InVivo Therapeutics Holdings Corp. operates as a research and clinical-stage biomaterials and biotechnology company in the United States. The company engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant comprise of biocompatible and bioresorbable polymers, which includes Poly lactic-co-glycolic acid, a polymer which is widely used in resorbable sutures and provides the biocompatible support for Neuro-Spinal Scaffold implant; and Poly-L-Lysine, a positively charged polymer used to coat surfaces to promote cellular attachment. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.", "fullTimeEmployees": 6, "companyOfficers": [{"maxAge": 1, "name": "Dr. Richard M. Toselli M.D.", "age": 65, "title": "President, CEO, Chief Medical Officer & Director", "yearBorn": 1958, "fiscalYear": 2022, "totalPay": 825204, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Richard C. Christopher", "age": 53, "title": "CFO & Treasurer", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": 537816, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Heather M. Hamel J.D.", "age": 33, "title": "Chief Legal Officer & General Counsel", "yearBorn": 1990, "fiscalYear": 2022, "totalPay": 446957, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert S. Langer Jr., Ph.D.", "age": 74, "title": "Co-Founder & Member of Scientific Advisory Board", "yearBorn": 1949, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Joseph Philip Vacanti M.D.", "age": 74, "title": "Co-Founder", "yearBorn": 1949, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.64, "open": 0.26, "dayLow": 0.2401, "dayHigh": 0.4, "regularMarketPreviousClose": 0.64, "regularMarketOpen": 0.26, "regularMarketDayLow": 0.2401, "regularMarketDayHigh": 0.4, "beta": 0.723, "forwardPE": -0.030648148, "volume": 1900629, "regularMarketVolume": 1900629, "averageVolume": 26601, "averageVolume10days": 20360, "averageDailyVolume10Day": 20360, "bidSize": 4000, "askSize": 1400, "marketCap": 1027903, "fiftyTwoWeekLow": 0.2401, "fiftyTwoWeekHigh": 2.48, "fiftyDayAverage": 0.7312, "twoHundredDayAverage": 1.08315, "currency": "USD", "enterpriseValue": -7553097, "floatShares": 2767201, "sharesOutstanding": 3105450, "sharesShort": 21043, "sharesShortPriorMonth": 5743, "sharesShortPreviousMonthDate": 1702598400, "dateShortInterest": 1705017600, "sharesPercentSharesOut": 0.0068, "heldPercentInsiders": 0.10647, "heldPercentInstitutions": 0.03447, "shortRatio": 0.77, "shortPercentOfFloat": 0.0076, "impliedSharesOutstanding": 3105450, "bookValue": 2.872, "priceToBook": 0.1152507, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -9327000, "trailingEps": -3.28, "forwardEps": -10.8, "lastSplitFactor": "1:25", "lastSplitDate": 1651017600, "enterpriseToEbitda": 0.77, "52WeekChange": -0.73109245, "SandP52WeekChange": 0.17144287, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "NVIV", "underlyingSymbol": "NVIV", "shortName": "InVivo Therapeutics Holdings Co", "longName": "InVivo Therapeutics Holdings Corp.", "firstTradeDateEpochUtc": 1289831400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "672db550-c94d-3efd-a20d-c75b136c2372", "messageBoardId": "finmb_112935519", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.331, "recommendationKey": "none", "totalCash": 8581000, "totalCashPerShare": 2.763, "ebitda": -9803000, "quickRatio": 12.884, "currentRatio": 14.302, "returnOnAssets": -0.53708, "returnOnEquity": -0.98107004, "freeCashflow": -7028000, "operatingCashflow": -10128000, "financialCurrency": "USD", "trailingPegRatio": null}]